Many insurance applications rely on general medication questions that may not reliably capture GLP-1 use, potentially affecting risk assessment
Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, and Butler PC
Department of Health and Human Services and the FDA published guidance for pharmaceutical companies that develop and produce antidiabetic medications
A slight yellow tint is normal and listed as acceptable in the FDA prescribing information
With an unwavering commitment to the craft, she is convinced that there is nothing else she was meant to do with her life
Yey M, Bajaj M, Yang HC, et al